Hopman Mark sold BBNX
September 16, 2026 · Form 4 insider transaction
Hopman Mark sold 30,779 shares of Beta Bionics, Inc. at $20.13 per share, a transaction worth $619.6K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
30,779
Price
$20.13
Total value
$619.6K
InsiderHopman Mark
RoleOfficer
CompanyBeta Bionics, Inc. (BBNX)
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 16, 2026
Filing dateSeptember 17, 2026
Shares owned after56,479
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on June 10, 2026.; The weighted average sale price for the transaction reported was $20.1319 and the range of prices were between $20.00 and $20.64. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.